comparemela.com

Pharmaceuticals Supply News Today : Breaking News, Live Updates & Top Stories | Vimarsana

EQS-News: Medios AG expects continued growth after record year in 2022 and plans further increase in profit margin Seite 1

30.03.2023 - EQS-News: Medios AG / Key word(s): Annual Report/Annual Results Medios AG expects continued growth after record year in 2022 and plans further increase in profit margin 30.03.2023 / 07:54 CET/CEST The issuer is solely responsible for the content . Seite 1

Newco pharma gmbSpecialty pharma solutionsNewco pharma groupNewco pharma gmbhPharmaceuticals supplyPatient specific therapiesNewco pharmaQs news

Medios AG expects continued growth after record year in 2022 and plans further increase in profit margin

EQS-News: Medios AG / Key word: Annual Report/Annual Results Medios AG expects continued growth after record year in 2022 and plans further increase in profit margin 30.03.2023 /. | March 30, 2023

Claudia nickolausMatthias gaertnerNewco pharma gmbNewco pharma groupMedios groupSpecialty pharma solutionsNewco pharma gmbhPharmaceuticals supplyPatient specific therapiesNewco pharmaChief executive officerSpecialty pharmaInvestor relationsRegulated marketFrankfurt stock exchangePrime standard

Medios AG expects continued growth after record year in 2022 and plans further increase in profit ma

EQS-News: Medios AG / Key word(s): Annual Report/Annual ResultsMedios AG expects continued growth after record year in 2022 and plans further increase in profit margin 30.03.2023 / 07:54 CET/CESTThe issuer is solely responsible for the content of this announcement.Press releaseMedios AG expects continued growth afte.

Newco pharma gmbMatthias gaertnerClaudia nickolausMedios groupNewco pharma groupDistribution servicesSpecialty pharma solutionsAnnual resultsNewco pharma gmbhPharmaceuticals supplyPatient specific therapiesNewco pharmaChief executive officerSpecialty pharmaInvestor relationsRegulated market

Investegate |GlaxoSmithKline PLC Announcements | GlaxoSmithKline PLC: Director/PDMR Shareholding

Investegate announcements from GlaxoSmithKline PLC, Director/PDMR Shareholding

United kingdomCity ofGlobal communicationsLondon stock exchangeGlobal healthFinancial conduct authorityGlobal affairsPharmaceuticals supply chainOrdinary sharesOrdinary sharesStock exchangeGroup general counselPharmaceuticals supplyLondon stockPrimary information providerInvestegate announcements

Investegate |GlaxoSmithKline PLC Announcements | GlaxoSmithKline PLC: Director/PDMR Shareholding

Investegate announcements from GlaxoSmithKline PLC, Director/PDMR Shareholding

City ofUnited kingdomYork stock exchangeGlobal communicationsLondon stock exchangeGlobal affairsPharmaceuticals supply chainGlobal healthCompany total shareholderPerformance share planOrdinary sharesAmerican depositary sharesPersons discharging managerial responsibilitiesPersons closely associatedShare planExecutive directors

vimarsana © 2020. All Rights Reserved.